NCT02762773

Brief Summary

The purpose of this study is to evaluate the effect of non-dissecting the inferior rectus sheath during primary cesarean delivery on post-operative hemoglobin and post-operative pain control as measured by VAS score and opioid anesthesia use in the first 72 hours post-op.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 3, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 5, 2016

Completed
1.7 years until next milestone

Study Start

First participant enrolled

February 1, 2018

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
Last Updated

December 16, 2021

Status Verified

December 1, 2021

Enrollment Period

3.6 years

First QC Date

May 3, 2016

Last Update Submit

December 1, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • post-operative hemoglobin

    assessment of drop in hemoglobin post-operatively compared to pre-operative values

    24 hours

Secondary Outcomes (2)

  • assessment of Visual Analog Scale (VAS) scores in first 72 hours

    72 hours

  • Assessment of total narcotic use, expressed as morphine equivalents

    72 hours

Study Arms (2)

Experimental

EXPERIMENTAL

Patients will undergo non-dissection of the inferior rectus sheath at time of primary cesarean delivery

Procedure: non-dissection of inferior rectus sheath

Control

PLACEBO COMPARATOR

Patients will undergo standard practice which is dissection of the superior and inferior rectus sheath at time of cesarean delivery

Procedure: control

Interventions

Non-dissection of inferior rectus sheath

Experimental
controlPROCEDURE

Dissection of inferior and superior aspect of the rectus sheath

Control

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Patients must be 18 years or older as well as willing and able to provide informed consent
  • Patients undergoing a scheduled or non-scheduled, non-urgent or non-scheduled urgent (delivery within 30 minutes of decision for surgical delivery) Cesarean delivery between \>35 weeks gestational age,
  • Patients who are expected to receive a Pfannenstiel incision
  • Patients with viable singleton intra-uterine pregnancy
  • Patients with fetus in cephalic presentation

You may not qualify if:

  • \- Patients younger than 18 years,
  • Patients unable or unwilling to provide informed consent,
  • Patients who are illiterate,
  • Patients who are non-English speaking or reading,
  • Patients who are medical or nursing students at a school affiliated with University Hospital
  • Multi-fetal gestations (\>1 intrauterine pregnancy),
  • Patients with a BMI \>50 kg/m\^2
  • Patients with a suspected placenta accreta or placenta previa
  • patients with 2 prior cesarean deliveries
  • Patient undergoing emergent cesarean delivery (delivery within 10 minutes of decision for surgical delivery)
  • Patients who will require a vertical skin incision, Maylard or Cherney incisions
  • Patients with a history of significant pelvic adhesive disease, as determined by prior operative reports
  • Patients with fetus in non-cephalic presentation
  • Patients with pre-gestational or gestational diabetes mellitus
  • Patients with estimated fetal weight \>5000 grams
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UH Cleveland Medical Center

Cleveland, Ohio, 44106, United States

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Martin Wieczorek, MD

    University Hospitals Cleveland Medical Center

    STUDY DIRECTOR
  • Melissa March, MD

    University Hospitals Cleveland Medical Center

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 3, 2016

First Posted

May 5, 2016

Study Start

February 1, 2018

Primary Completion

September 1, 2021

Study Completion

September 1, 2021

Last Updated

December 16, 2021

Record last verified: 2021-12

Locations